Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: An Italian multicenter prospective observational study
| Autor: | Millul, A., Iudice, A., Adami, M., Porzio, R., Mattana, F., Beghi, E., Theorem study group, Benna, Paolo, Colonna, R., Rosso, M., Montalenti, Elisa |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Time Factors Adolescent Cohort Studies Young Adult Behavioral Neuroscience Epilepsy Drug withdrawal Indirect costs epilessia Quality of life farmaci antiepilettici medicine Humans In patient Child Adverse effect studio di coorte Aged Aged 80 and over business.industry Middle Aged medicine.disease Add on therapy Italy Neurology Child Preschool Physical therapy Anticonvulsants Drug Therapy Combination Female Observational study Neurology (clinical) business |
| Zdroj: | Epilepsy & Behavior. 28:494-500 |
| ISSN: | 1525-5050 |
| Popis: | A prospective multicenter observational study was undertaken on children and adults with epilepsy in whom first monotherapy failed, to assess indications and effects of alternative monotherapy vs. polytherapy. Patients were followed until 12-month remission, drug withdrawal, or up to 18months. Monotherapy and polytherapy were compared for patients' baseline features, indication, retention time, remission, adverse events (AE), quality of life, and direct and indirect costs. Included were 157 men and 174 women, aged 2-86years. Of the patients, 72.2% were switched to alternative monotherapy. Baseline treatment was changed for lack of efficacy (73.9%) or adverse events (26.1%). Two hundred forty-three completed the study (remission: 175; 72.0%). Retention time, hospital admissions, days off-work and off-school, and quality of life did not differ between the two treatment groups. Patients were followed for 365.3person-years. Three hundred eighty-three incident AEs were reported by 46.4% of patients in monotherapy and 40.2% in polytherapy (serious AEs: 9.6% vs. 8.7%, mostly nondrug-related). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect